Enterra Medical
Description
In 2022, Enterra Medical was formed to focus exclusively on helping more people find relief through Enterra Therapy—a device that was originally approved by the FDA in 2000 under a Humanitarian Device exemption and received the Conformité Européene (CE) mark in March 2002. Enterra Medical is dedicated to leading the way in therapy innovation and support for people living with gastroparesis.
Unlike diet modifications or surgery, the Enterra System is the first and only device designed to relieve chronic nausea and vomiting symptoms. A small, implantable device that’s customizable and reversible, the Enterra System gently stimulates your stomach, which is designed to help reduce the nausea and vomiting associated with gastroparesis. And over 20,000 people have already received Enterra Therapy.
Through the power of Enterra Therapy, Enterra Medical seeks to equip healthcare providers with a reversible advanced treatment option so that they can finally offer hope—and help—to patients living with gastroparesis.